Vγ4Vδ1 TCR Lentivirus
Vγ4Vδ1 TCR Lentivirus are replication incompetent, HIV-based, VSV-G-pseudotyped lentiviral particles ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. These viruses transduce a TCR (T Cell Receptor) which belongs to the Vγ4Vδ1 subtype of γδ TCRsd. The TCR γ chain and δ chain are linked by P2A. The lentiviruses also transduce a puromycin selection marker (Figure 1).
Figure 1. (A) Schematic of the lenti-vector used to generate the Vγ4Vδ1 TCR Lentivirus and (B) diagram of the construct, showing the components of the Vγ4Vδ1 TCR.
TRGV and TRGC correspond to the TCR γ chain variable and constant regions, respectively, whereas TRDV and TRDC correspond to the TCR δ chain variable and constant regions.
Name | Ordering Information |
Thaw Medium 2 | BPS Bioscience #60184 |
Growth Medium 2B | BPS Bioscience #79530 |
Growth Medium 2F | BPS Bioscience #79669 |
TCR Knockout NFAT-Luciferase Reporter Jurkat Cell Line | BPS Bioscience #78556 |
Anti-CD3 Agonist Antibody | BPS Bioscience #71274 |
TCR Vδ1 Antibody, anti-human, PE, REAfinity™ | Miltenyi Biotech #130-120-580 |
TCR V delta 2 Monoclonal Antibody (15D) | Life Technologies #TCR1732 |
TCR V delta 1 Monoclonal Antibody (TS8.2) | Life Technologies #TCR1730 |
ONE-Step™ Luciferase Assay System | BPS Bioscience #60690 |
Lenti-Fuse Polybrene Viral Transduction Enhancer | BPS Bioscience #78939 |
The lentiviruses were produced in HEK293T cells in medium containing 90% DMEM + 10% FBS. Virus particles can be packaged in custom formulations by special request, for an additional fee.
γδ TCRs (T cell receptors), αβ TCRs, and antibodies, result from gene rearrangements and offer the immune system the possibility to recognize several different types of antigens. γδ TCRs recognize antigens in a similar way to antibodies, being able to recognize full protein antigens and being independent on antigen binding to the MHC (major histocompatibility complex). γδ TCRs are cell type-specific, with Vγ4Vδ1 being present in γδTIL (tumor infiltrating lymphocytes) cells. Vδ1 expressing cells are found in mucosal and epithelial tissues and correspond to about 15% of the γδT cells present in PBMCs, with the % of γδ being only 5% of all the T cells. Vγ4Vδ1 cells can be activated by CD1 (cluster of differentiation 1) and respond to BTNL3 (butyrophilin-like 3), BTNL8, annexin A2 and A6. These cells can lead to tumor cell death by lysis. While most of the studies have been focusing on Vγ9Vδ2 T cells, a better understanding of the function and therapeutic potential of Vγ4Vδ1 T cells may open new avenues in cancer therapy.
Allison T. and Garboczi D., 2002 Molecular Immunology 38 (14): 1051-1061.
Song Y., et al., 2022 Front Immunol 13: 914839.